Literature DB >> 12667323

[Immunohistochemical spectrum in the detection and differentiation of intrahepatic neoplasms].

Wenming Cong1, Lu Tan, Shuhui Zhang, Zhihong Xian, Weiqing Wu, Jing Pan, Xiuzhong Zhang.   

Abstract

OBJECTIVE: To scrutinize the immunohistochemical spectrum to differentiate hepatocellular carcinoma (HCC) from intrahepatic cholangiocarcinoma (ICC) and metastatic adenocarcinoma (MAC) in the liver.
METHODS: Seven antibodies including AFP, Hep Par 1, CK18, CK19, CA19-9, CD34 and pCEA were immunohistochemically stained in resected specimens of 300 HCC, 35 ICC and 30 MAC. The specificity and sensitivity of the antibodies were evaluated by comprehensive capability score (CCS), with only those with CCS > or = 8 considered as having highly diagnostic value.
RESULTS: Antibodies CCS > or = 8 were observed as Hep Par 1 and CD34 in HCC, and CK19 in ICC, but none in MAC. For HCC, CCS of Hep Par 1 was higher than that of AFP (9 vs. 7) with 83.7% in sensitivity and 96.7% in specificity.
CONCLUSION: For HCC, Hep Par 1 and CD34 can be used as the first line antibodies, AFP and pCEA as the second line ones. CK19 is the first line antibody for ICC, and CA19-9 as the second. Hep Par 1, CD34 and CK19 are definitely helpful for the routine immunohistochemical stain to differentiate HCC from ICC and MAC.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12667323

Source DB:  PubMed          Journal:  Zhonghua Zhong Liu Za Zhi        ISSN: 0253-3766


  2 in total

Review 1.  Surgicopathological classification of hepatic space-occupying lesions: a single-center experience with literature review.

Authors:  Wen-Ming Cong; Hui Dong; Lu Tan; Xu-Xu Sun; Meng-Chao Wu
Journal:  World J Gastroenterol       Date:  2011-05-21       Impact factor: 5.742

2.  Dermoscopy of cutaneous metastases from primary hepatocellular carcinoma.

Authors:  Xiao-Yang Liu; Jiang Jin; Si Zhang; Heng Zhang; Yan Zhao; Lin Cai; Jian-Zhong Zhang
Journal:  Chin Med J (Engl)       Date:  2019-09-05       Impact factor: 2.628

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.